Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a regular profit — if it can wrest control of a ...
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström MacroglobulinemiaFirst-in-class ...
Police have charged two men following an ongoing investigation into the alleged drug supply in the state's north. In January 2025, officers attached to Mid North Coast Police District established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results